tiprankstipranks
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
CNQX:SPLY
Canadian Market

Origin Therapeutics Holdings, Inc. (SPLY) Financial Statements

2 Followers

Origin Therapeutics Holdings, Inc. Financial Overview

Origin Therapeutics Holdings, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.361; its P/E ratio is -0.06; Origin Therapeutics Holdings, Inc. is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.03MC$ -2.48M-C$ -64.17KC$ -2.15M
EBITDAC$ -1.03MC$ -2.48M-C$ -64.17KC$ -2.15M
Net Income Common StockholdersC$ -1.03MC$ -2.48M-C$ -64.17KC$ -2.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.39MC$ 1.92MC$ 3.77MC$ 3.07MC$ 3.33M
Total AssetsC$ 2.28MC$ 2.79MC$ 4.22MC$ 3.19MC$ 3.37M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -1.39MC$ -1.92MC$ -3.77MC$ -3.07MC$ -3.33M
Total LiabilitiesC$ 553.20KC$ 432.14KC$ 2.26MC$ 109.86KC$ 223.89K
Stockholders EquityC$ 1.72MC$ 2.36MC$ 1.95MC$ 3.08MC$ 3.15M
Cash Flow-
Free Cash Flow-C$ -1.81M-C$ -259.85KC$ -87.08K
Operating Cash Flow-C$ -1.79M-C$ -259.85KC$ -87.08K
Investing Cash Flow-C$ -412.63K--C$ 7.74K
Financing Cash Flow-----
Currency in CAD

Origin Therapeutics Holdings, Inc. Earnings and Revenue History

Origin Therapeutics Holdings, Inc. Debt to Assets

Origin Therapeutics Holdings, Inc. Cash Flow

Origin Therapeutics Holdings, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis